Skip to main content
Clinical Trials/JPRN-jRCTs052180083
JPRN-jRCTs052180083
Recruiting
Phase 2

Exploratory study of efficacy and safety of transcutaneous CO2 application for post-polio syndrome. - Effect of CO2 therapy on post-polio syndrome

Sakai Yoshitada0 sites10 target enrollmentFebruary 28, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Sakai Yoshitada
Enrollment
10
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 28, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sakai Yoshitada

Eligibility Criteria

Inclusion Criteria

  • 1 Patients of post\-polio syndrome with muscle weekness
  • 2 Aged over 20 yrs
  • 3 Patients who can consent in writting

Exclusion Criteria

  • 1 Ichemic limb (Fontaine 3\-4\)
  • 2 Chronic heart failure (NYHA 4\)
  • 3 Precnancy (including possibility)
  • 4 Respiratory failure (%VC\<60%)
  • 5\. Sever anemia (Hb \<7\.0g/dl)
  • 6\. Large skin ulcer, skin trouble
  • 7 Resercher's detamination of unsuitable of this study

Outcomes

Primary Outcomes

Not specified

Similar Trials